AMED Ventures’ 2026 Annual LP Meeting Concludes Successfully
AMED Ventures held its 2026 Annual LP Meeting in Taipei on Thursday, September 10.
AMED
News
2026 AMED Ventures International Medical Forum Highlights Innovation in AI, Robotics, and Medical Imaging
On September 10, 2026, AMED Ventures hosted its Annual International Medical Forum under the theme “Redefining Healthcare: A New Generation of Clinical Therapy Driven by AI, Robotics, and Medical Imaging.” The event welcomed more than 100 guests from the healthcare, technology, and investment communities.
AMED
Redefining Healthcare: A New Generation of Clinical Therapy Driven by AI, Robotics, and Medical Imaging
AMED Ventures will convene an international medical forum in Taipei exploring how AI, robotics, medical imaging, and clinical needs are shaping the next generation of healthcare innovation.
AMED
Rejoni Receives FDA Approval of the Juveena® Hydrogel System to Reduce Intrauterine Adhesions Following Hysteroscopic Adhesiolysis
Rejoni announced FDA premarket approval for its Juveena® Hydrogel System. The device is approved for adult women undergoing hysteroscopic surgery to treat symptomatic moderate to severe intrauterine adhesions, helping reduce both the occurrence and severity of postoperative adhesions.
Portfolio
Rejonibusinesswire.com
Rejoni Secures $25 Million to Accelerate the Juveena Hydrogel System Toward FDA Approval and Launch
Rejoni announced the closing of a $25 million financing to advance the Juveena Hydrogel System toward FDA approval and launch.
Portfolio
Rejonibusinesswire.com
OrthoIndy, Indiana Hand to Shoulder Center First in Indiana to Use New Technology During Combined Amputation and Peripheral Nerve Procedure
Tulavi Therapeutics' new hydrogel platform is bringing hope to trauma and amputation patients at risk of developing symptomatic neuromas.
Portfolio
Tulavi Therapeuticsblog.orthoindy.com
Benthic Genomics Adds Mako to the Benthic Analysis Platform for High-Resolution Immune-Region Analysis From Short-Read Sequencing Data
Benthic Genomics announced the launch of Mako, a short-read immunogenomics analysis module on the Benthic Analysis Platform.
Portfolio
Benthic Genomicsbenthic.bio
Supira Gets FDA Green Light to Conduct Ventricular Assist Device Study
Supira Medical received FDA approval to initiate a new trial of its percutaneous ventricular assist device.
Portfolio
Supira Medicalmassdevice.com
Imperative Care initiates CLEAR-IT clinical study
Imperative Care announced the enrollment of the first patient in the CLEAR-IT clinical study.
Portfolio
Imperative Carevascularnews.com
Randomized Controlled Trial Demonstrated Positive Outcomes for FDA-Cleared Brain-Computer Interface IpsiHand® System in Chronic Stroke Rehabilitation
Kandu announced positive outcomes from a randomized controlled trial of the FDA-cleared IpsiHand brain-computer interface system.
Portfolio
Kanduprnewswire.com
Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System
Instylla announced the first commercial use of its Embrace Hydrogel Embolic System for peripheral vascular embolization.
Portfolio
Instyllaprnewswire.com
FDA Files Rejoni's Juveena Hydrogel System PMA for the Prevention of Intrauterine Adhesions
Rejoni announced that the FDA filed its premarket approval application for the Juveena Hydrogel System.
Portfolio
Rejonibusinesswire.com
Tulavi Therapeutics Receives Innovative Technology Contract from Vizient for the allay™ Hydrogel Cap
Tulavi Therapeutics announced that its allay Hydrogel Cap received an Innovative Technology contract from Vizient.
Portfolio
Tulavi Therapeuticsprnewswire.com
Benthic Genomics Launches Angler Imputation Platform, Making High-Resolution Immunogenomics Accessible to All Researchers
Benthic Genomics announced the commercial launch of Angler Imputation on its cloud-based analysis platform.
Portfolio
Benthic Genomicsbenthic.bio
Adona Medical Completes Enrollment in First-in-Human Interatrial Shunt Trial
Adona Medical completed enrollment in the ATHENS-HF first-in-human study of its interatrial shunt.
Portfolio
Adona Medicalmassdevice.com
FDA Grants Atia Vision Approval to Begin US Clinical Trial of OmniVu Lens System in Patients with Cataracts
Atia Vision received FDA approval to begin a U.S. clinical trial of its OmniVu Lens System in patients with cataracts.
Portfolio
Atia Visionbusinesswire.com
Kandu Health, Neurolutions Merge Into BCI Company Targeting Stroke Care
Kandu Health and Neurolutions merged to form Kandu Inc. and establish a new standard of care for stroke recovery.
Portfolio
Kandumassdevice.com
Ostial Corp. Rebrands as Verge Medical, Acquires New Technology
Ostial Corp. acquired the Wavella technology from Crossfire Medical and unveiled its new identity as Verge Medical.
Portfolio
Verge Medicaldicardiology.com
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
Instylla completed its premarket approval application submission for the Embrace Hydrogel Embolic System.
Portfolio
Instyllaprnewswire.com
Rejoni Completes Patient Enrollment in Pivotal Clinical Study of the Juveena Hydrogel System
Rejoni completed patient enrollment in its pivotal clinical study of the Juveena Hydrogel System.
Portfolio
Rejonibusinesswire.com
Tioga Cardiovascular Completes First-in-Human Mitral Valve Replacement Cases
Tioga Cardiovascular announced the first-in-human implants of its Luna transcatheter mitral valve replacement system.
Portfolio
Tioga Cardiovascularmassdevice.com
Adona Medical, a Shifamed Portfolio Company, Raises $33.5 Million in Series C Financing
Adona Medical secured $33.5 million in Series C financing to advance solutions for heart failure.
Portfolio
Adona Medicalprnewswire.com
Akura Medical Secures $35M to Pursue FDA Clearance for Thrombectomy Device
The financing will support clinical trials, additional indications and expanded manufacturing capabilities for Akura Medical's thrombectomy platform.
Portfolio
Akura Medicalmedtechdive.com
Sealonix, Inc. Closes $20 Million Financing to Develop Sealant Products for Abdominopelvic and Orthopedic Procedures
Sealonix closed a $20 million Series A financing led by Excelestar Ventures.
Portfolio
Sealonixprnewswire.com
康聚醫學科技 全臺唯一醫療級金屬線材廠
康聚醫學科技是全臺唯一、全球少數的醫療用金屬線材供應商，承襲廣泰金屬集團四十多年的金屬加工技術。
Portfolio
KT Medicalnews.gbimonthly.com
康聚醫學科技進軍心導管醫材
康聚醫學科技憑藉專業抽線與自主修模技術，跨足醫療線材產業並開發心導管微創手術醫材。
Portfolio
KT Medicalctee.com.tw
Adjustable Interatrial Shunt for Heart Failure Shows Promise in First-in-Human Trial
Early ATHENS-HF trial data showed promise for an adjustable interatrial shunt in patients with heart failure.
Portfolio
Adona Medicalcardiovascularbusiness.com
Akura Begins Pivotal Trial of Katana Thrombectomy System in Pulmonary Embolism
Akura Medical began a pivotal trial of the Katana thrombectomy system in patients with pulmonary embolism.
Portfolio
Akura Medicalevtoday.com
Akura Raises Financing for Thrombectomy System and Quantification Software
Akura Medical secured financing to advance its thrombectomy system and clot-quantification software.
Portfolio
Akura Medicalevtoday.com
Imperative Care Launches Ikon 24
Imperative Care launched Ikon 24 as the latest addition to its comprehensive stroke-care portfolio.
Portfolio
Imperative Carefinance.yahoo.com
Imperative Care Nets $100M Financing
Imperative Care raised $100 million to support its portfolio of technologies for stroke and vascular care.
Portfolio
Imperative Carefiercebiotech.com
Novo Holdings co-leads $120 million Series E Financing of Supira Medical to Advance Percutaneous Ventricular Assist Device Technology
Novo Holdings co-led a $120 million Series E financing to advance Supira Medical's percutaneous ventricular assist device technology.
Portfolio
Supira Medicalnovoholdings.dk
EuroPCR 2026 Presentation
The presentation reports initial outcomes for the Luna Mitral Valve Replacement System in patients with symptomatic mitral regurgitation.
Portfolio
Tioga Cardiovasculareuropcr2026.europa-inviteo.com
FDA Clears Surgical Hydrogel Nerve Cap for Preventing Phantom Limb Pain
Tulavi Therapeutics received FDA clearance for an absorbable hydrogel cap designed to protect the end of a severed nerve.
Portfolio
Tulavi Therapeuticsfiercebiotech.com